StockNews.com initiated coverage on shares of IRIDEX (NASDAQ:IRIX – Free Report) in a research note issued to investors on ...

( MENAFN - Mid-East Info) The Retina clinic London will showcase cutting-edge innovations in the diagnosis, monitoring, and ...

While much attention is given to the painful crises, anaemia, and organ damage caused by SCD, its impact on vision is equally ...

“That light, from the laser, is focused on a very small area of the retina. That part of the retina has what we call ...

ABBV-RGX-314 in Diabetic Retinopathy (DR), Suprachoroidal Delivery AbbVie and REGENXBIO will plan a Phase 3 clinical program. The clinical program will utilize the in-office SCS Microinjector ® to ...

Abstract: Diabetic retinopathy (DR) is a severe complication of diabetes that affects the retinal structures and can lead to significant visual impairment or even blindness. Early diagnosis is crucial ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.